2179 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. It focuses on innovative technology platforms such as novel adjuvant, protein engineering, and immunological evaluation platforms. The company was founded by Yong Liu on May 18, 2012 and is headquartered in Taizhou City, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
2179 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company